이원석 교수 연구실
article|
bronze
·인용수 0
·2023
993P Thyroid dysfunction after atezolizumab and bevacizumab is associated with favorable outcomes in hepatocellular carcinoma (IMbrave150 and Korean patients cohorts)
Hong Jae Chon, Yu Song, He Yang, I. Kim, Hye‐Young Kim, Won Suk Lee, Yun Beom Sang, C. Kim
IF 56.7Annals of Oncology
키워드
MedicineAtezolizumabInternal medicineBevacizumabThyroidOncologyThyroid cancerHepatocellular carcinomaAdverse effectGastroenterology